Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00141180 | CP-481,715 Nickel Allergy Study. | PHASE1 | COMPLETED | 48 | — | — | Sep 1, 2003 | Oct 1, 2005 | Jul 25, 2006 | 5 | United States, Denmark |
| Name | Type | Description |
|---|---|---|
| CP-481,715 | DRUG | - |
Inclusion Criteria: * A history of nickel allergy confirmed by a visual positive reaction (graded at least ++) to T.R.U.E. TEST. Exclusion Criteria: * Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic,...